PL2211858T3 - Zastosowanie czwartorzędowych soli pirydyniowych do hamowania przerzutów nowotworowych - Google Patents
Zastosowanie czwartorzędowych soli pirydyniowych do hamowania przerzutów nowotworowychInfo
- Publication number
- PL2211858T3 PL2211858T3 PL08805180T PL08805180T PL2211858T3 PL 2211858 T3 PL2211858 T3 PL 2211858T3 PL 08805180 T PL08805180 T PL 08805180T PL 08805180 T PL08805180 T PL 08805180T PL 2211858 T3 PL2211858 T3 PL 2211858T3
- Authority
- PL
- Poland
- Prior art keywords
- pyridinium salts
- inhibiting cancer
- cancer metastases
- quaternary pyridinium
- quaternary
- Prior art date
Links
- 206010027476 Metastases Diseases 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99885107P | 2007-10-12 | 2007-10-12 | |
| EP07465008 | 2007-10-12 | ||
| PCT/EP2008/063535 WO2009047291A2 (en) | 2007-10-12 | 2008-10-09 | Use of quaternary pyridinium salts for inhibiting cancer metastases |
| EP08805180.0A EP2211858B1 (en) | 2007-10-12 | 2008-10-09 | Use of quaternary pyridinium salts for inhibiting cancer metastases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2211858T3 true PL2211858T3 (pl) | 2015-06-30 |
Family
ID=40122493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08805180T PL2211858T3 (pl) | 2007-10-12 | 2008-10-09 | Zastosowanie czwartorzędowych soli pirydyniowych do hamowania przerzutów nowotworowych |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2211858B1 (pl) |
| PL (1) | PL2211858T3 (pl) |
| WO (1) | WO2009047291A2 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017298648B2 (en) * | 2016-07-18 | 2023-05-11 | Pharmena S.A. | 1-methylnicotinamide for the treatment of diseases associated with C-reactive protein |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT131118B (de) | 1929-04-19 | 1933-01-10 | Ig Farbenindustrie Ag | Verfahren zur Darstellung von N-Methylpyridiniumchlorid. |
| US3614408A (en) | 1969-02-20 | 1971-10-19 | British Petroleum Co | Waveform analyzing system, particularly for chromatographs, wherein the waveform is integrated between selected peaks and valleys |
| US4115390A (en) | 1977-08-19 | 1978-09-19 | Nardi John C | Method for the preparation of 1-alkyl pyridinium chlorides |
| PL190755B1 (pl) | 1999-01-07 | 2006-01-31 | Pharmena Sp Z Oo | Preparat do leczenia i profilaktyki chorób skóry |
| PL364348A1 (pl) * | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Zastosowanie czwartorzędowych soli pirydyniowych jako środka naczynioprotekcyjnego |
| WO2006024545A1 (en) * | 2004-09-03 | 2006-03-09 | Stichting Voor De Technische Wetenschappen | Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes |
| ES2418153T3 (es) * | 2006-03-08 | 2013-08-12 | Cortria Corporation | Terapia de combinación con inhibidores no selectivos de COX para prevenir lesiones gástricas relacionadas con COX |
-
2008
- 2008-10-09 PL PL08805180T patent/PL2211858T3/pl unknown
- 2008-10-09 WO PCT/EP2008/063535 patent/WO2009047291A2/en not_active Ceased
- 2008-10-09 EP EP08805180.0A patent/EP2211858B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| EP2211858A2 (en) | 2010-08-04 |
| WO2009047291A2 (en) | 2009-04-16 |
| EP2211858B1 (en) | 2015-03-25 |
| WO2009047291A3 (en) | 2009-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2488449B (en) | System for determination of downhole position | |
| GB2478472B (en) | Cables for downhole use | |
| PT3517534T (pt) | Compostos uteis para o tratamento de cancro | |
| GB0712345D0 (en) | Downhole apparatus | |
| IL216015A0 (en) | Quaternary ammonium salt compounds | |
| ZA201204063B (en) | 2-pyridone compounds | |
| IL202373A0 (en) | Aryl ether pyridazinone derivatives | |
| BRPI0811433A2 (pt) | compostos do tipo triazolil aminopirimidina | |
| IL205666A0 (en) | Pyridine compounds | |
| GB0710480D0 (en) | Downhole apparatus | |
| PT2638033E (pt) | Compostos úteis para inibir chk1 | |
| EP2168350A4 (en) | INFORMATION EXCHANGE METHODS | |
| GB0721013D0 (en) | New Salts | |
| SI2129377T1 (sl) | Tekoäśa formulacija soli 4-(2-(4-metilfenilsulfanil)fenil)piperidina | |
| IL225520A0 (en) | History of 4-(methylaminophenoxy)pyridin-3-yl-benzamide for cancer treatment | |
| GB201012319D0 (en) | Cables for downhole use | |
| PL2211858T3 (pl) | Zastosowanie czwartorzędowych soli pirydyniowych do hamowania przerzutów nowotworowych | |
| BRPI0818892A2 (pt) | Síntese de compostos de sal quaternário | |
| PL2211857T3 (pl) | Zastosowanie czwartorzędowych soli pirydyniowych do radioprotekcji | |
| GB201001983D0 (en) | Corner fixing bracket for shower riser bar | |
| AP2717A (en) | Mono-hydrochloric salts of an inhibitor of histonedeacetylase | |
| GB0823224D0 (en) | Cables for downhole use | |
| GB0714728D0 (en) | Salts | |
| GB0703460D0 (en) | Disposal of metal salts | |
| GB201020030D0 (en) | Downhole centraliser |